Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition used for inflammation anaphylaxis skin diseases

A composition and allergic technology, which is applied in the direction of drug combination, allergic diseases, skin diseases, etc., can solve the problems of western medicines such as large side effects, poor effect, and easy recurrence, and achieve quick results, significant curative effect, and no toxic side effects Effect

Inactive Publication Date: 2019-10-08
TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of inflammatory allergic skin diseases, especially eczema, is mainly based on western medicine, especially hormone drugs, but the side effects of western medicine are large, and there are also reports of related traditional Chinese medicine preparations for eczema, but the effect is not good and it is easy to relapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition used for inflammation anaphylaxis skin diseases
  • Pharmaceutical composition used for inflammation anaphylaxis skin diseases
  • Pharmaceutical composition used for inflammation anaphylaxis skin diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1, the preparation of medicine of the present invention

[0032] Formula: Phellodendron 80g, Fructus Cnidii 40g, Nanhanshuishi 20g, Chishizhi 40g, Liquid Paraffin 60g, Yellow Vaseline 665g, Glycerin 95g, and the finished product is 1000g

[0033] Preparation:

[0034] (1) Weigh the raw and auxiliary materials according to the formula;

[0035] (2) Mix Nanhanshui stone and red stone fat, crush through a 100-mesh sieve to obtain fine powder A; mix Phellodendron and Cnidium Fructus, and crush through a 100-mesh sieve to obtain fine powder B; mix yellow petrolatum and glycerin, and store at 60°C to 70°C Heat to a fluid state, and stir to obtain a fluid mixture;

[0036] (3) Mix fine powder A and fine powder B, mix with liquid paraffin, stir to form a uniform paste mixture, add fluid mixture and mix well to obtain.

Embodiment 2

[0037] Embodiment 2, the preparation of medicine of the present invention

[0038] Formula: Phellodendron 56g, Fructus Cnidii 28g, Nanhanshui stone 14g, red stone fat 28g, liquid paraffin 52g, yellow petrolatum 465.5g, glycerin 66.5g.

[0039] Preparation:

[0040] (1) Weigh the raw and auxiliary materials according to the formula;

[0041] (2) Mix Nanhanshui stone and red stone fat, crush through a 100-mesh sieve to obtain fine powder A; mix Phellodendron and Cnidium Fructus, and crush through a 100-mesh sieve to obtain fine powder B; mix yellow petrolatum and glycerin, and store at 60°C to 70°C Heat to a fluid state, and stir to obtain a fluid mixture;

[0042] (3) Mix fine powder A and fine powder B, mix with liquid paraffin, stir to form a uniform paste mixture, add fluid mixture and mix well to obtain.

Embodiment 3

[0043] Embodiment 3, the preparation of medicine of the present invention

[0044] Formula: Phellodendron 104g, Fructus Cnidii 52g, Nanhanshui stone 26g, red stone fat 52g, liquid paraffin 78g, yellow petrolatum 864.5g, glycerin 123.5g.

[0045] Preparation:

[0046] (1) Weigh the raw and auxiliary materials according to the formula;

[0047] (2) Mix Nanhanshui stone and red stone fat, crush through a 100-mesh sieve to obtain fine powder A; mix Phellodendron and Cnidium Fructus, and crush through a 100-mesh sieve to obtain fine powder B; mix yellow petrolatum and glycerin, and store at 60°C to 70°C Heat to a fluid state, and stir to obtain a fluid mixture;

[0048] (3) Mix fine powder A and fine powder B, mix with liquid paraffin, stir to form a uniform paste mixture, add fluid mixture and mix well to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition used for inflammatory anaphylaxis skin diseases. The pharmaceutical composition used for the inflammatory anaphylaxis skin diseases is prepared from the following bulk drugs in parts by weight: 56-104 parts of cortex phellodendri, 28-52 parts of fructus cnidii, 14-26 parts of calcite calcitum, and 28-52 parts of red kaoline. The pharmaceutical composition used for the inflammatory anaphylaxis skin diseases has obvious anti-allergy, anti-pruritic and anti-inflammatory effects on eczema with remarkable and quick curative effects, no toxic sideeffects, no adverse reactions, no recurrence, and is safe and convenient.

Description

technical field [0001] The invention specifically relates to a pharmaceutical composition for inflammatory allergic skin diseases. Background technique [0002] Inflammatory allergic skin diseases are skin diseases caused by allergens. Specific allergens can be divided into four categories: contact allergens, inhalation allergens, ingestion allergens, and injection allergens. Each type of allergen can cause corresponding allergic skin diseases, the main manifestations are various dermatitis, eczema, and urticaria. [0003] Eczema is an inflammatory allergic skin disease characterized by recurrent attacks and severe itching. It often occurs in children and adults. About 18% of children and 5% of adults worldwide suffer from eczema. Its clinical symptoms are mainly manifested as erythema, exfoliation of the epidermis, and even lichenification, which seriously affects the healthy life of patients. Modern research has found that eczema is closely related to allergy, inflammati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/756A61P17/00A61P37/08A61K33/10A61K33/26
CPCA61K33/10A61K33/26A61K36/234A61K36/756A61P17/00A61P37/08A61K2300/00
Inventor 陈明岭孙涛艾儒棣余志杰肖敏余倩颖艾华方明
Owner TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com